Hughes, J., Reuter, A., Chabalala, B., Isaakidis, P., Cox, H., & Mohr, E. (2019). Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting. The international journal of tuberculosis and lung disease, 23(9), 1017. https://doi.org/10.5588/ijtld.18.0651
Citace podle Chicago (17th ed.)Hughes, J., A. Reuter, B. Chabalala, P. Isaakidis, H. Cox, a E. Mohr. "Adverse Events Among People on Delamanid for Rifampicin-resistant Tuberculosis in a High HIV Prevalence Setting." The International Journal of Tuberculosis and Lung Disease 23, no. 9 (2019): 1017. https://doi.org/10.5588/ijtld.18.0651.
Citace podle MLA (9th ed.)Hughes, J., et al. "Adverse Events Among People on Delamanid for Rifampicin-resistant Tuberculosis in a High HIV Prevalence Setting." The International Journal of Tuberculosis and Lung Disease, vol. 23, no. 9, 2019, p. 1017, https://doi.org/10.5588/ijtld.18.0651.